UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005487
Receipt number R000006500
Scientific Title Intergroup trial: Randomized Phase II Clinical Trial of Pegylated Liposomal Doxorubicin plus Carboplatin versus Gemcitabine plus Carboplatin in Platinum-Sensitive Patients with Recurrent Epithelial Ovarian Carcinoma, Primary Carcinoma of FallopianTube, and Peritoneal Carcinoma after Failure of Initial Platinum-based Chemotherapy
Date of disclosure of the study information 2011/04/22
Last modified on 2018/08/20 11:09:38

No. Disposal Last modified on Item of update
1 Insert 2011/04/22 13:12:01
2 Update 2011/04/26 09:46:15 Recruitment status
Anticipated trial start date
3 Update 2011/04/26 09:50:08 Institutions
4 Update 2011/05/16 10:19:29 Institutions
5 Update 2011/07/28 12:10:21 Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
6 Update 2011/07/28 12:13:11 Recruitment status
7 Update 2011/10/24 09:33:17 Institutions
8 Update 2012/04/23 18:27:20 Institutions
9 Update 2012/10/22 09:34:33 Institutions
10 Update 2013/01/15 10:04:28 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2013/04/23 13:03:08 Division name
Institutions
12 Update 2013/05/27 15:47:24 Institutions
13 Update 2013/10/22 09:43:01 Email
Email
Institutions
14 Update 2014/04/28 09:33:37 Institutions
15 Update 2014/10/22 10:07:41 Institutions
16 Update 2014/11/11 09:30:31 Recruitment status
Date of protocol fixation
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
17 Update 2015/04/22 11:35:14 Name of person sending information
Name of person sending information
18 Update 2018/08/20 11:09:02 Recruitment status
Results
19 Update 2018/08/20 11:09:38 Recruitment status